Toggle navigation
Home
Search
Services
Blog
Contact
About
Proinhibitors of Colon Carcinogenesis
Lam, Luke K.
Lkt Laboratories, Inc., St. Paul, MN, United States
Search 18 grants from Luke Lam
Search grants from Lkt Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
M4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficits
Monocytes in Dry Age-Related Macular Degeneration
Naive T cell depletion to prevent graft-versus-host disease
Impact of Corticotropin Releasing Factor (CRF) on Sleep Regulation
Development of Vaccines Against Retrovirus Infection
Recently added grants:
Project 4: Evaluating mediation effects of the microbiome and epigenetics using high dimensional assays
GABAA Receptor-Mediated Modulation of Lung Inflammation
Epigenomics of mononuclear phagocytes in prematurity associated lung disease
Tie2-driven vascular control in critical illness
Mechanisms of Stress-Induced Hypertension
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA062663-01A5S1
Application #
2777521
Study Section
Special Emphasis Panel (ZRG2 (01))
Program Officer
Miller, William C
Project Start
1997-05-05
Project End
1998-09-30
Budget Start
1997-05-05
Budget End
1998-09-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Lkt Laboratories, Inc.
Department
Type
DUNS #
City
St. Paul
State
MN
Country
United States
Zip Code
55114
Related projects
NIH 1998
R43 CA
Proinhibitors of Colon Carcinogenesis
Lam, Luke K. / Lkt Laboratories, Inc.
NIH 1997
R43 CA
Proinhibitors of Colon Carcinogenesis
Lam, Luke K. / Lkt Laboratories, Inc.
Comments
Be the first to comment on this grant